Machine Learning

Heart Disease Risk Analyzer

Machine learning system for the predictive assessment of heart disease, achieving 88.6% accuracy and providing an instantaneous risk analysis.

Executive Summary

This project addresses the need for rapid and accessible preliminary health screenings by developing and deploying an AI-powered web application that provides an instantaneous risk assessment for heart disease. The tool serves as an efficient, data-driven first step for individuals to evaluate their cardiovascular health profile.
The application is built on a K-Nearest Neighbors (KNN) machine learning model, which achieves a validated accuracy of 88.6%. The interactive user interface was developed using Streamlit and features a real-time risk visualization gauge powered by Plotly. The complete end-to-end project is version-controlled with Git/GitHub and deployed live on Streamlit Cloud, demonstrating a robust and modern MLOps workflow.

The key impact of this project is the drastic reduction in assessment time, transforming a traditionally lengthy process into an immediate insight. The result is a fully functional, user-friendly tool that makes proactive health monitoring more accessible and empowers users to make informed decisions promptly.

Problem Statement & Business Context

This project tackles the critical delay in heart disease screening by providing an instant, AI-powered risk assessment. It closes the gap between public health needs and accessible digital tools, empowering users to proactively manage their health and enabling more efficient healthcare triage.

  • Reduces Screening Time: Provides an instant risk analysis, eliminating traditional wait times.
  • Increases Accessibility:: Offers a free, on-demand tool for immediate preliminary screening.
  • Encourages Proactive Health: Empowers users with early insights before symptoms arise.
  • Improves Triage: Helps prioritize healthcare resources toward high-risk individuals.

This app serves to augment, not replace, a formal diagnosis. It offers an instant, preliminary screening that highlights potential risk, empowering users to seek professional medical review.